There are 3158 resources available
Expanding proteome interrogation to identify early phase clinical trial biomarkers
Presenter: Janne Lehtiö
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Surgery for persistent cervical cancer after chemoradiation
Presenter: Nadeem Abu-Rustum
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Slides
Webcast
Invited Discussant 1539MO, 1540MO and 1541MO
Presenter: Christine Chomienne
Session: Mini oral session: Policy and preventive strategies
Resources:
Slides
Webcast
Future directions in the development and use of Real World Evidence
Presenter: Miriam Koopman
Session: How Real World Data (RWD) are transforming oncology
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Webcast
Invited Discussant 1241MO, 1206MO and 1207MO
Presenter: Heather Wakelee
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Webcast
LBA78 - Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial
Presenter: Hans Gelderblom
Session: Proffered paper session: Sarcoma
Resources:
Abstract
Slides
Webcast
1542MO - Mapping the scale of off-label use in oncology: An important step in harmonising access
Presenter: Hans Timmer
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
68O - Frequency of clinical acquired RAS-MAPK pathway resistance alterations in patients treated with KRASG12C inhibitors: An individual patient meta-analysis
Presenter: Jakob Riedl
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Abstract
Slides
Webcast